ClinicalTrials.gov
public full text
Public Domain
Dextromethorphan in Fibromyalgia
The objective of this protocol is to evaluate if Dextromethorphan (DXM) reduces Fibromyalgia (FM) pain. DXM is a drug found in several over-the-counter products, including cough suppressants. The drug may reduce FM pain by suppressing inflammation in the central nervous system. The investigators will be observing the effects of DXM on daily self-reported pain measures in people with FM. If DXM reduces FM pain, it will provide important information about the nature of FM pathophysiology.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia#1072825
- Low Dose Naltrexone (LDN) Immune Monitoring#1151259
- NSAID vs. Narcotics#1164415
- Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects#1338223
- A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department#845452
Record · ID 1337144
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive